Molecular and clinical characterization of Colombian patients suffering from type III glycogen storage disease
Introduction: Type III glycogen storage disease (GSD III) is an autosomal recessive disorder in which a mutation in the AGL gene causes deficiency of the glycogen debranching enzyme. The disease is characterized by fasting hypoglycemia, hepatomegaly and progressive myopathy. Molecular analyses of AG...
Main Authors: | Carolina Mantilla, Mónica Toro, María Elsy Sepúlveda, Margarita Insuasty, Diana di Filippo, Juan Álvaro López, Carolina Baquero, María Cristina Navas, Andrés Augusto Arias |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto Nacional de Salud
2018-05-01
|
Series: | Biomédica: revista del Instituto Nacional de Salud |
Subjects: | |
Online Access: | https://www.revistabiomedica.org/index.php/biomedica/article/view/3454 |
Similar Items
-
A Novel Gene Therapy Approach for GSD III Using an AAV Vector Encoding a Bacterial Glycogen Debranching Enzyme
by: Jeong-A Lim, et al.
Published: (2020-09-01) -
The Novel Compound Heterozygous Mutations in the AGL Gene in a Chinese Family With Adult Late-Onset Glycogen Storage Disease Type IIIa
by: Qianqian Qu, et al.
Published: (2020-11-01) -
The role of glycogen phosphorylase in glycogen biogenesis in skeletal muscle after exercise
by: Abram Katz
Published: (2023-03-01) -
Sodium valproate increases the brain isoform of glycogen phosphorylase: looking for a compensation mechanism in McArdle disease using a mouse primary skeletal-muscle culture in vitro
by: Noemí de Luna, et al.
Published: (2015-05-01) -
Decreased Glycogenolysis by miR-338-3p Promotes Regional Glycogen Accumulation Within the Spinal Cord of Amyotrophic Lateral Sclerosis Mice
by: Chunyu Li, et al.
Published: (2019-05-01)